Integrating phosphoproteome and transcriptome reveals new determinants of macrophage multinucleation

Maxime Rotival1, Jeong-Hun Ko2, Prashant K Srivastava1

  • 1From the ‡Integrative Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, UK;

Insights

Researchers identified novel regulators of macrophage multinucleation (MM) by integrating phosphoproteomics and RNA-sequencing. Key findings reveal metabolic shifts and specific protein changes driving this essential biological process.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Macrophage multinucleation (MM) is crucial for bone resorption and inflammatory responses.
  • Understanding the molecular mechanisms of MM is vital for various physiological and pathological processes.

Purpose of the Study:

  • To identify novel molecular regulators of macrophage multinucleation.
  • To elucidate the interplay between transcriptomic and phosphoproteomic changes during MM.

Main Methods:

  • Integrative analysis of MS-based quantitative phosphoproteomics (LC-MS/MS) and high-throughput RNA-sequencing in rat macrophages.
  • Shortest-path analysis to correlate differential phosphorylation with transcriptomic reprogramming.
  • Experimental validation using gene knockdown to assess the role of identified regulators.

Main Results:

  • A significant metabolic shift towards HIF1-mediated glycolysis was observed at the transcriptomic level during MM.
  • Over 50 proteins showed altered phosphorylation, including ARF GTPase activators and polyphosphate inositol phosphatases.
  • LRRFIP1, SMARCA4, and DNMT1 were identified as novel regulators of MM, with knockdown reducing multinucleation.

Conclusions:

  • The study provides a novel framework for analyzing combined transcriptional and post-translational changes in MM.
  • Identified regulators (LRRFIP1, SMARCA4, DNMT1) offer potential therapeutic targets.
  • Revealed sequential molecular events leading to macrophage multinucleation.